Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
<p>Cancer testis antigens (CTA) represent attractive targets for targeted radiotherapy and imaging as their expression is restricted to cancer and germ cells. NY-ESO-1, a member of the CTA family, is highly immunogenic and expressed in multiple tumor types including carcinoma of bladder, liver...
Prif Awdur: | |
---|---|
Awduron Eraill: | |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2013
|
Pynciau: |